Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
Roche Corleen M. exercised options for 49,995 Iovance Biotherapeutics, Inc. shares (Form 4)
Traded Aug 6, 2026 · Filed Aug 10, 2026
On Aug 6, 2026, Roche Corleen M. (Chief Financial Officer) exercised options for 49,995 Iovance Biotherapeutics, Inc. shares, leaving 28,757 shares. Filed Aug 10, 2026 (Form 4).
- Options exercised
- 49,995 shares
- Holding after
- 28,757 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Option exercise | 49,995 | 49,995 | Direct | |
| Aug 6, 2026 | Common Stock | Shares withheld for tax | 21,238 | US$6.21 | 28,757 | Direct |